Short Bowel Clinical Trials

18 recruitingLast updated: May 13, 2026

There are 18 actively recruiting short bowel clinical trials across 18 countries. Studies span Not Applicable, Phase 3, Phase 2, Early Phase 1, Phase 1. Top locations include Boston, Massachusetts, United States, Guangzhou, Guangdong, China, Copenhagen, Denmark. Updated daily from ClinicalTrials.gov.


Short Bowel Trials at a Glance

18 actively recruiting trials for short bowel are listed on ClinicalTrialsFinder across 6 cities in 18 countries. The largest study group is Not Applicable with 6 trials, with the heaviest enrollment activity in Boston, Guangzhou, and Copenhagen. Lead sponsors running short bowel studies include Takeda, Chongqing Peg-Bio Biopharm Co., Ltd., and Central Hospital, Nancy, France.

Browse short bowel trials by phase

Treatments under study

About Short Bowel Clinical Trials

Looking for clinical trials for Short Bowel? There are currently 1 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Short Bowel trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Short Bowel clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 118 of 18 trials

Recruiting
Phase 2

Phase 2 Study to Assess the Safety, PK, and PD of Sonefpeglutide (HM15912) in SBS-IF Subjects

Short Bowel Syndrome
Hanmi Pharmaceutical Company Limited18 enrolled14 locationsNCT04775706
Recruiting
Not Applicable

Effect of GLP-1 on Intestinal Barrier Function in SBS-IF Patients: A Preliminary Exploration.

intestinal failureShort Bowel Syndrome (SBS)
Jinling Hospital, China20 enrolled2 locationsNCT07297238
Recruiting
Phase 3

Efficacy And Safety Evaluation of Glepaglutide in Treatment of SBS

Short Bowel Syndrome
Zealand Pharma90 enrolled23 locationsNCT07197944
Recruiting

A Study of Teduglutide in Chinese Children and Teenagers With Short Bowel Syndrome

Short Bowel Syndrome (SBS)
Takeda12 enrolled4 locationsNCT07319832
Recruiting
Phase 3

Efficacy and Safety of PJ009 in Patients With Short Bowel Syndrome Requiring Parenteral Nutrition

Short Bowel Syndrome
Chongqing Peg-Bio Biopharm Co., Ltd.72 enrolled8 locationsNCT06512584
Recruiting
Not Applicable

Elemental 028 Extra Case Studies

MalabsorptionAllergiesGastrointestinal Disease+3 more
Nutricia UK Ltd30 enrolled1 locationNCT06877923
Recruiting
Early Phase 1

Open-Label Pilot Study With Crofelemer in Patients With Short Bowel Syndrome

Short Bowel Syndrome
Lindsey Russell, MD6 enrolled1 locationNCT06326645
Recruiting

SBS DISK- Creation of a Quality of Life Tool for Short Bowel Patients Compared With a Validated Quality of Life Questionnaire (SBS QoL)

Short Bowel Syndrome
Hospices Civils de Lyon100 enrolled1 locationNCT06771505
Recruiting
Not Applicable

TED_ORG: Study on Short Bowel Syndrome

Short Bowel Syndrome (SBS)
Meyer Children's Hospital IRCCS50 enrolled1 locationNCT07400783
Recruiting

A Survey to Assess Participants' and Physicians' Knowledge When Using GATTEX (Knowledge Assessment Survey)

Short Bowel Syndrome (SBS)
Takeda600 enrolled1 locationNCT05561647
Recruiting
Not Applicable

A 90 Day, Phase 3,Open Labeled Exploratory Study of RELiZORB

MalabsorptionShort Bowel Syndrome
Boston Children's Hospital32 enrolled1 locationNCT03530852
Recruiting
Not Applicable

A Feasibility Study to Evaluate Safety and Probable Benefit of the Eclipse XL1 System for Distraction Enterogenesis in Adult and Pediatric Patients With Short Bowel Syndrome

Short Bowel Syndrome
Eclipse Regenesis, Inc.40 enrolled6 locationsNCT05535361
Recruiting
Phase 3

A Study of Teduglutide in Chinese Adults With Short Bowel Syndrome

Short Bowel Syndrome
Takeda13 enrolled4 locationsNCT06973304
Recruiting
Phase 2

Safety and Efficacy of Crofelemer in Adult Patients With Short Bowel Syndrome and Intestinal Failure (SBS-IF) Without Colon-in-continuity (CIC)

Short Bowel SyndromeFunctional Gastrointestinal DisordersPost-Op Complication+2 more
Napo Therapeutics, S.p.A.18 enrolled8 locationsNCT06904872
Recruiting

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford

Multiple Endocrine Neoplasia Type 1Multiple Endocrine Neoplasia Type 2Rare Disorders+337 more
Sanford Health20,000 enrolled2 locationsNCT01793168
Recruiting

A Study of Teduglutide in Japanese People With Short Bowel Syndrome

Short Bowel Syndrome
Takeda120 enrolled2 locationsNCT05023382
Recruiting
Phase 1

Absorption of Antibiotics With High Oral Bioavailability in Short-bowel Syndrome

Short Bowel SyndromeInfection, Bacterial
Central Hospital, Nancy, France10 enrolled1 locationNCT05302531
Recruiting
Not Applicable

Efficacy Evaluation of UCB-MNCs in the Treatment of Refractory Neonatal Diseases

Short Bowel SyndromeBronchopulmonary DysplasiaHypoxic-ischemic encephalopathy.
Shandong Qilu Stem Cells Engineering Co., Ltd.120 enrolled1 locationNCT06427642